RelB is a potential molecular biomarker for immunotherapy in human pan-cancer
Introduction: The nuclear factor kB (NF-κB) pathway emerges as a critical regulator of immune responses and is often dysregulated in human cancers. It consists of a family of transcription factors involved in many biological responses. Activated NF-κB subunits results in the nuclear translocation an...
| Prif Awduron: | , , , , , , , |
|---|---|
| Fformat: | Erthygl |
| Iaith: | English |
| Cyhoeddwyd: |
Frontiers Media S.A.
2023-06-01
|
| Cyfres: | Frontiers in Molecular Biosciences |
| Pynciau: | |
| Mynediad Ar-lein: | https://www.frontiersin.org/articles/10.3389/fmolb.2023.1178446/full |